We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-4.69%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.7B
AUM Growth
-$972M
Cap. Flow
+$106M
Cap. Flow %
0.72%
Top 10 Hldgs %
23.63%
Holding
875
New
75
Increased
357
Reduced
296
Closed
67

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$90.2M
2
MRK icon
Merck
MRK
+$70M
3
ADBE icon
Adobe
ADBE
+$55.1M
4
BKNG icon
Booking.com
BKNG
+$34.5M
5
NOW icon
ServiceNow
NOW
+$30.3M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$51.3M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$40.4M
3
CRM icon
Salesforce
CRM
+$36.7M
4
INFO
IHS Markit Ltd. Common Shares
INFO
+$36.4M
5
ARNA
Arena Pharmaceuticals Inc
ARNA
+$30.1M

Sector Composition

Rank Sector Weight
1 Healthcare 29.35%
2 Technology 26.36%
3 Financials 8.78%
4 Communication Services 7.85%
5 Consumer Discretionary 7.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EA icon
151
Electronic Arts
EA
$52.4B
$22.7M 0.15%
179,118
-85,329
-32% -$11.1M
MRNA icon
152
Moderna
MRNA
$22.1B
$22.4M 0.15%
130,250
-39,014
-23% -$6.57M
HES
153
DELISTED
Hess
HES
$22.3M 0.15%
208,504
+192,239
+1,182% +$18.2M
CDNS icon
154
Cadence Design Systems
CDNS
$95.1B
$22.1M 0.15%
134,433
-5,486
-4% -$842K
FTNT icon
155
Fortinet
FTNT
$110B
$22.1M 0.15%
323,010
-15,605
-5% -$970K
ITOS
156
DELISTED
iTeos Therapeutics
ITOS
$22M 0.15%
683,812
-73,515
-10% -$2.67M
PFE icon
157
Pfizer
PFE
$144B
$21.2M 0.14%
408,741
-34,336
-8% -$1.78M
TSC
158
DELISTED
TriState Capital Holdings, Inc.
TSC
$20.9M 0.14%
628,274
+420,984
+203% +$13.4M
EW icon
159
Edwards Lifesciences
EW
$48.2B
$20.7M 0.14%
175,818
+22,278
+15% +$2.5M
CMG icon
160
Chipotle Mexican Grill
CMG
$43B
$20.7M 0.14%
652,800
+18,050
+3% +$544K
DPZ icon
161
Domino's
DPZ
$11.6B
$20.6M 0.14%
50,689
+46,016
+985% +$20.1M
LULU icon
162
lululemon athletica
LULU
$13.7B
$20.5M 0.14%
56,138
+6,796
+14% +$2.21M
VZ icon
163
Verizon
VZ
$201B
$20.4M 0.14%
400,751
+143,149
+56% +$7.58M
BMY icon
164
Bristol-Myers Squibb
BMY
$130B
$20.3M 0.14%
278,274
-30,317
-10% -$2.04M
NUE icon
165
Nucor
NUE
$60.5B
$20.3M 0.14%
136,518
-43,108
-24% -$5.29M
BBY icon
166
Best Buy
BBY
$18.9B
$19.7M 0.13%
216,743
+55,758
+35% +$5.53M
INTC icon
167
Intel
INTC
$435B
$19.7M 0.13%
396,590
-301,329
-43% -$14.9M
KDNY
168
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$19.4M 0.13%
1,185,314
+80,412
+7% +$1.09M
ASND icon
169
Ascendis Pharma A/S
ASND
$16.7B
$19.3M 0.13%
164,318
-74,104
-31% -$8.58M
IOVA icon
170
Iovance Biotherapeutics
IOVA
$2.1B
$19.2M 0.13%
1,152,585
+256,221
+29% +$3.96M
CRL icon
171
Charles River Laboratories
CRL
$11.6B
$19.2M 0.13%
67,530
-62,879
-48% -$19.4M
FRC
172
DELISTED
First Republic Bank
FRC
$18.9M 0.13%
116,738
+65,859
+129% +$11.5M
ALLY icon
173
Ally Financial
ALLY
$13.4B
$18.8M 0.13%
431,303
+19,099
+5% +$902K
KLAC icon
174
KLA
KLAC
$249B
$18.6M 0.13%
506,840
+21,510
+4% +$804K
IONS icon
175
Ionis Pharmaceuticals
IONS
$9.14B
$18.5M 0.13%
499,547
-437,088
-47% -$14.3M
5 6
7
8 9

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2022 Portfolio in Review

As of Q1 2022, Candriam SCA held 875 positions worth $14.7B, down 6.2% from $15.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q1 2022 filing shows 75 new, 357 increased, 296 reduced and 67 closed positions. Its largest new stake was Ecopetrol: 1,389,000 shares worth $25.8M. The largest sale was Amgen, an estimated $51.3M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 31% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2022 buy was Ecopetrol: 1,389,000 shares worth $25.8M.
  • Candriam SCA added most to Walt Disney in Q1 2022, an estimated $90.2M increase.
  • Candriam SCA's biggest Q1 2022 reduction was Amgen, cutting an estimated $51.3M.
  • Candriam SCA fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $36.4M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.7B portfolio in Q1 2022.
  • Candriam SCA opened 75 new positions and closed 67 in Q1 2022.
  • Candriam SCA's portfolio value fell 6.2% quarter-over-quarter to $14.7B.

Based on Candriam SCA's 13F filing for Q1 2022, filed 13 May 2022.